Quantcast

Latest Takeda Pharmaceutical Company Stories

2014-10-27 12:29:42

ZURICH, October 27, 2014 /PRNewswire/ -- - Cross reference: Picture is available at epa european pressphoto agency (http://www.epa.eu) and http://www.presseportal.de/pm/111920

2014-10-20 23:02:17

RnRMarketResearch.com adds “Hypertension – Pipeline Review, H2 2014” to its store.

2014-10-18 23:02:44

Another Actos Lawsuit Purports Patient Develop Bladder Cancer After Taking The Type Two Diabetes Medication Columbus, OH (PRWEB) October 18, 2014 Wright

2014-10-18 16:21:09

DALLAS, October 18, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Autism - Pipeline Review, H2 2014" and "Endometriosis - Pipeline Review, H2 2014" market research reports

2014-10-17 23:02:58

RnRMarketResearch.com adds “Osteoporosis & Osteoarthritis – Pipeline Review, H2 2014” to its store.

2014-10-10 23:03:39

The Philadelphia jury awarded the man $2 million: Actos was deemed a contributing factor to the man’s bladder cancer, Takeda was found to have not warned physicians concerning the drug’s cancer

2014-10-08 16:26:22

Pegasus Legal Funding LLC Can Provide Financial Assistance to Those Adversely Affected NEW YORK, Oct.

2014-10-05 23:01:59

The Actos Lawsuit Purports Takeda Pharmceuticals Knew Long-Term Use Of The Medication Could Potentially Lead To Bladder Cancer. Columbus, OH (PRWEB) October

2014-10-03 16:24:45

Expresses Continued Confidence in ACTOS DEERFIELD, Ill., Oct. 3, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related